A recent study found that the use of Levonorgestrel-Releasing Intrauterine Systems (LNG-IUS) for contraception is associated with a slightly elevated risk of breast cancer. The study involved 78,595 women between the ages of 15 and 49 who began using the intrauterine system between 2000 and 2019. After an average follow-up period of 6.8 years, 1,617 participants were diagnosed with breast cancer. Experts noted that while there is a small increase in breast cancer risk with hormonal contraception, the overall benefits of hormonal contraception outweigh the risks. It is recommended that women near 40 years of age discuss non-hormonal modes of contraception with their healthcare provider.
Source link
Common Hormonal IUD For Contraception Raises Breast Cancer Risk: Study Finds
